ZYME logo

ZYME
Zymeworks Inc

2,595
Mkt Cap
$1.85B
Volume
193,378.00
52W High
$29.75
52W Low
$11.02
PE Ratio
-18.36
ZYME Fundamentals
Price
$25.67
Prev Close
$25.11
Open
$25.33
50D MA
$25.67
Beta
0.92
Avg. Volume
611,907.27
EPS (Annual)
-$1.08
P/B
11.31
Rev/Employee
$401,382.58
$1,775.10
Loading...
Loading...
News
all
press releases
Zymeworks (ZYME) Q1 2026 Earnings Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
News Placeholder
More News
News Placeholder
Zymeworks Inc. (ZYME) Reports Q1 Loss, Misses Revenue Estimates
Zymeworks (ZYME) delivered earnings and revenue surprises of -510.13% and -94.63%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
News Placeholder
uniQure (QURE) Reports Q1 Loss, Misses Revenue Estimates
uniQure (QURE) delivered earnings and revenue surprises of +2.86% and -48.75%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
News Placeholder
Pictet Asset Management Holding SA Invests $1.97 Million in Zymeworks Inc. $ZYME
Pictet Asset Management Holding SA purchased a new position in shares of Zymeworks Inc. (NASDAQ:ZYME - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing...
News Placeholder
Vertex Pharmaceuticals (VRTX) Q1 Earnings and Revenues Beat Estimates
Vertex (VRTX) delivered earnings and revenue surprises of +5.76% and +0.19%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
News Placeholder
Kornitzer Capital Management Inc. KS Takes $2.34 Million Position in Zymeworks Inc. $ZYME
Kornitzer Capital Management Inc. KS bought a new stake in Zymeworks Inc. (NASDAQ:ZYME - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and...
News Placeholder
Zymeworks (ZYME) Projected to Post Earnings on Thursday
Zymeworks (NASDAQ:ZYME) will be releasing its Q1 2026 earnings after the market closes on Thursday, May 7. (View Earnings Report at...
News Placeholder
Zymeworks (NASDAQ:ZYME) Raised to Strong-Buy at Truist Financial
Truist Financial raised Zymeworks to a "strong-buy" rating in a research report on Monday...
News Placeholder
Zymeworks (NASDAQ:ZYME) Hits New 52-Week High - Time to Buy?
Zymeworks (NASDAQ:ZYME) Reaches New 12-Month High - Should You Buy...
News Placeholder
Zymeworks Highlights Royalty-Fueled Pivot at Bloom Burton, Eyes Multibillion-Dollar Ziihera
Zymeworks (NASDAQ:ZYME) used a presentation at the Bloom Burton conference to outline how the company is repositioning itself around its first approved product and a growing stream of royalty and...
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available